131 related articles for article (PubMed ID: 8183562)
1. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells.
Ogawa S; Toyoshima H; Kozutsumi H; Hagiwara K; Sakai R; Tanaka T; Hirano N; Mano H; Yazaki Y; Hirai H
Oncogene; 1994 Jun; 9(6):1669-78. PubMed ID: 8183562
[TBL] [Abstract][Full Text] [Related]
2. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
3. Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk.
Wang B; Mysliwiec T; Feller SM; Knudsen B; Hanafusa H; Kruh GD
Oncogene; 1996 Oct; 13(7):1379-85. PubMed ID: 8875975
[TBL] [Abstract][Full Text] [Related]
4. Shb is a ubiquitously expressed Src homology 2 protein.
Welsh M; Mares J; Karlsson T; Lavergne C; Bréant B; Claesson-Welsh L
Oncogene; 1994 Jan; 9(1):19-27. PubMed ID: 8302579
[TBL] [Abstract][Full Text] [Related]
5. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells.
Ferris HA; Tapia JA; García LJ; Jensen RT
Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015
[TBL] [Abstract][Full Text] [Related]
6. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
[TBL] [Abstract][Full Text] [Related]
7. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
Reichman CT; Mayer BJ; Keshav S; Hanafusa H
Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
[TBL] [Abstract][Full Text] [Related]
8. Ankyrin repeat domain 28 (ANKRD28), a novel binding partner of DOCK180, promotes cell migration by regulating focal adhesion formation.
Tachibana M; Kiyokawa E; Hara S; Iemura S; Natsume T; Manabe T; Matsuda M
Exp Cell Res; 2009 Mar; 315(5):863-76. PubMed ID: 19118547
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
Jung JH; Pendergast AM; Zipfel PA; Traugh JA
Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
[TBL] [Abstract][Full Text] [Related]
10. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
[TBL] [Abstract][Full Text] [Related]
11. CrkIII: a novel and biologically distinct member of the Crk family of adaptor proteins.
Prosser S; Sorokina E; Pratt P; Sorokin A
Oncogene; 2003 Jul; 22(31):4799-806. PubMed ID: 12894221
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
[TBL] [Abstract][Full Text] [Related]
13. c-Src association with and phosphorylation of p58gag, a membrane- and microfilament-associated retroviral Gag-like protein in a xenotransplantable rat mammary tumor.
Huang J; Zhang BT; Li Y; Mayer B; Carraway KL; Carraway CA
Oncogene; 1999 Jul; 18(28):4099-107. PubMed ID: 10435591
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the SH2 and SH3 domains of the lck tyrosine protein kinase.
Reynolds PJ; Hurley TR; Sefton BM
Oncogene; 1992 Oct; 7(10):1949-55. PubMed ID: 1408136
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
Oda T; Kujovich J; Reis M; Newman B; Druker BJ
Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
[TBL] [Abstract][Full Text] [Related]
17. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
Jackson PK; Paskind M; Baltimore D
Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
[TBL] [Abstract][Full Text] [Related]
18. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
19. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
[TBL] [Abstract][Full Text] [Related]
20. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
